Gujarat Kidney And Super Speciality Limited (NSE:GKSL)

India · Delayed Price · Currency is INR

156.87

+0.50 (0.32%)

At close: Nov 12, 2026

Market Cap	12.37B
Revenue (ttm)	1.26B +156.0%
Net Income	190.07M +68.3%
EPS	2.50 +19.0%
Shares Out	78.84M
PE Ratio	62.84
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	279,658
Open	156.93
Previous Close	156.37
Day's Range	156.00 - 160.00
52-Week Range	98.36 - 209.80
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 4, 2026

About NSE:GKSL

Gujarat Kidney and Super Speciality Limited operates multi-specialty and super-specialty hospitals in India. It provides treatment for Oncology, Neurology, Gastroenterology, Urology, Nephrology, and Physiotherapy. It also offers Renal Surgery, Vascular Surgery, Gynecology and obstetrics, Robotic Surgery, Bariatric Surgery, Laparoscopic Surgery, Endocrine Surgery, Neurosurgery, and Joint Replacement services. Its facilities include intensive care unit, rooms, patient counselling, operation theatres, and dialysis center. Gujarat Kidney And Super ... [Read more]

Industry Medical Care Facilities

Sector Healthcare

Founded 2014

Employees 194

Stock Exchange National Stock Exchange of India

Ticker Symbol GKSL

Full Company Profile

Financial Performance

In fiscal year 2026, NSE:GKSL's revenue was 820.13 million, an increase of 103.80% compared to the previous year's 402.42 million. Earnings were 154.97 million, an increase of 64.63%.

Financial Statements